v3.26.1
FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 31, 2026
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 9: FAIR VALUE MEASUREMENTS

The following table sets forth by level, within the fair value hierarchy, the Company’s assets and liabilities, including financial liabilities for which the Company has elected the fair value option, measured and recorded at fair value on a recurring basis as of March 31, 2026: 

  ​ ​ ​

Level I

  ​ ​ ​

Level II

  ​ ​ ​

Level III

  ​ ​ ​

Total

Liabilities

Derivative liabilities

$

$

$

292,677

$

292,677

3(a)(10) Settlement Agreement

3,687,000

3,687,000

Contingent consideration*

236,832

236,832

Convertible debt

6,593,923

6,593,923

Total liabilities

$

$

$

10,810,432

$

10,810,432

*

Contingent Consideration also includes current portion of crystallized contingent consideration amounting to $510,556 and RJZ settlement amounting to $1,024,002 which are not included in the table above as these are not fair valued.

The following table sets forth by level, within the fair value hierarchy, the Company’s liabilities, including financial liabilities for which the Company has elected the fair value option, measured and recorded at fair value on a recurring basis as of December 31, 2025: 

  ​ ​ ​

Level I

  ​ ​ ​

Level II

  ​ ​ ​

Level III

  ​ ​ ​

Total

Assets

Forward purchase agreement

$

$

$

$

Total assets

$

$

$

$

Liabilities

Derivative liabilities

$

$

$

234,389

$

234,389

3(a)(10) Settlement Agreement

3,634,000

3,634,000

Contingent consideration*

330,226

330,226

Convertible debt

5,321,303

5,321,303

Total liabilities

$

$

$

9,519,918

$

9,519,918

*

Contingent Consideration also includes current portion of crystallized contingent consideration amounting to $417,163 and RJZ settlement amounting to $1,024,001 which are not included in the table above as these are not fair valued.

The following table provides a reconciliation of our assets and liabilities measured at fair value using Level 3 inputs:

  ​ ​ ​

Forward
Purchase
Agreement

  ​ ​ ​

Derivative liabilities

  ​ ​ ​

3(a)(10)
Settlement
Agreement

  ​ ​ ​

Contingent
consideration (1)

  ​ ​ ​

Convertible debt

Balance, December 31, 2025

$

$

(234,389)

$

(3,634,000)

$

(330,226)

$

(5,321,303)

Cash payment/(receipt)

533,890

Issuances

(1,861,000)

Commitment shares issued

102,030

Settlement through issuance of Company’s common stock

93,198

Change in fair value

(58,288)

(53,000)

(104,238)

Loss on issuance of financial instruments

(36,500)

Reclass from level 3

93,394

Ending balance, March 31, 2026

$

$

(292,677)

$

(3,687,000)

$

(236,832)

$

(6,593,923)

(1)Contingent Consideration also includes current portion of crystallized contingent consideration amounting to $510,556 and RJZ settlement amounting to $1,024,002 which are not included in the table above as these are not fair valued.

Fair Value of Level 3 Financial Instruments

Certain financial instruments, including SEPA convertible notes, instruments related to 3(a)10 Settlement Agreement and Derivative Liabilities contain embedded features that require bifurcation and measurement at fair value under ASC 815. These instruments are classified within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs.

In prior periods, the Company utilized a Monte Carlo simulation model to estimate fair value where valuation depended on future stock price variability and path-dependent assumptions. As of March 31, 2026, for certain convertible notes, the reset provisions were based on the Company’s closing stock price at year-end and were not dependent on future contingent events, and accordingly fair value was determined using the intrinsic value of the reset feature at the measurement date. For other convertible notes where the settlement outcome remained uncertain, the Company applied a probability-weighted pay-off approach, assigning probabilities to each potential settlement scenario (e.g., cash repayment, conversion, or default) to estimate the fair value of the embedded derivative at the reporting date.

Convertible Notes Payable

The Company’s carrying value and fair value for the convertible notes payable for which the Company elected the fair value option is as follows:

March 31, 2026

December 31, 2025

  ​ ​ ​

Carrying Value

  ​ ​ ​

Fair Value

  ​ ​ ​

Carrying Value

  ​ ​ ​

Fair Value

2025 Convertible Notes

$

3,236,210

$

3,649,413

$

3,212,250

$

3,778,303

2026 Convertible Notes

2,007,150

1,798,510

SEPA Convertible Note

$

991,135

1,146,000

1,386,975

1,543,000

$

6,234,495

$

6,593,923

$

4,599,225

$

5,321,303

The change in fair value on convertible debt resulted a loss of approximately $104,000 and $320,000 for the three months ended March 31, 2026 and 2025, respectively, which was recorded as a component of other income (expense) on the accompanying condensed consolidated statements of operations and comprehensive loss.

2026 Convertible Notes, and 2025 Convertible Notes: The 2026 Convertible Notes, and 2025 Convertible Notes are re-measured to fair value at each reporting period using the following relevant assumptions:

  ​ ​ ​

March 31, 2026

  ​ ​ ​

December 31, 2025

Discount rate

20.0-201.0

%

20.0 - 65.0

%

Probability of conversion at maturity scenario

50.0-95.0

%

30.0 -100.0

%

Probability of voluntary conversion scenario/event of default scenarios

5.0-50.0

%

0.0 - 70.0

%

Remaining term for conversion at maturity scenario/event of default scenarios

0.25 years

0.01 - 0.52 years

Remaining term for voluntary conversion scenario

0.36 years

0.01 - 0.52 years

SEPA Convertible Note:

The fair value measurement of the SEPA Convertible Note is classified within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs (refer to Note 7).

The fair value of the SEPA Convertible Note as of March 31, 2026 was $1,146,000, as determined by an independent third-party valuation firm using a discounted cash flow methodology applied to the scheduled installment payments. The key assumptions used in the valuation were as follows:

Assumptions

  ​ ​ ​

March 31, 2026

  ​ ​ ​

December 31, 2025

Valuation technique

Discounted cash flow
of scheduled
installment payments

Discounted cash flow
of scheduled
installment payments

Outstanding balance

$

991,135

1,386,975

Bi-weekly payment amount

250,000

250,000

Expected IPO / settlement date

June 30, 2026

March 31, 2026

Discount rate

16.0

%

15.0

%

Fair value of outstanding balance

$

978,000

1,368,000

Termination fee (payable in Common Stock at IPO price)

$

168,000

175,000

Fair value of SEPA (post-termination)

$

Total fair value of Pre-Paid Advance Obligation

$

1,146,000

1,543,000

The discount rate of 16.0% was selected based on an analysis of market-based rates of return, including the ICE BofA CCC & Lower US High Yield Index (13.9%), the S&P U.S. High Yield Corporate Bond CCC index (16.8%), and the Pepperdine Private Capital Markets mezzanine required rate of return (19.0%). The fair value measurement is subject to estimation uncertainty, as it is sensitive to changes in the discount rate and the timing of the expected IPO. Pursuant to the Settlement and Termination Agreement, the SEPA was terminated, and its value was determined to be zero; accordingly, the remaining obligation consists solely of the scheduled installment payments and the termination fee.

3(a)(10) Settlement Agreement

On January 28, 2025, the Company entered into a Settlement Agreement and Stipulation (the “Settlement Agreement”) with Last Horizon, LLC (“Last Horizon”), pursuant to which the Company agreed to issue shares of its common stock to Last Horizon in exchange for the settlement of bona fide outstanding liabilities totaling approximately $8,908,077 (the “Claim”) that Last Horizon had acquired from various Company creditors. The Settlement Agreement was approved by the Circuit Court of the 12th Judicial Circuit of the State of Florida, and the issuance of common stock to Last Horizon is exempt from the registration requirements of the Securities Act pursuant to Section 3(a)(10) thereof.

The Company elected the fair value option under ASC 825 for the 3(a)(10) Settlement Agreement obligation. The obligation represents a freestanding financial instrument indexed to the Company’s common stock and is classified as a liability in accordance with ASC 480, as it embodies an obligation that may be settled with a variable number of shares. The liability is remeasured at fair value at each reporting date, with changes in fair value recognized in other (expense) income, net in the consolidated statements of operations and comprehensive loss.

The change in fair value of the 3(a)(10) Settlement Agreement obligation resulted in a loss of approximately $53,000 and $606,000 for the three months ended March 31, 2026 and 2025, respectively.

The fair value measurement is classified within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs. As of March 31, 2026, the fair value of the 3(a)(10) Settlement Agreement obligation was $3,687,000, as determined by an independent third-party valuation firm using a Monte Carlo simulation with 50,000 trials under a scenario-based framework. The valuation considered two scenarios: (i) a base case scenario (95.0% probability), under which the Conversion Price equals the lower of $1.09 or 85.0% of the market price, and (ii) a default scenario (5.0% probability), under which the Conversion Price (pre-split) equals the lower of $1.09 or 75.0% of the market price. The Company’s stock price was simulated using Geometric Brownian Motion through the expected last share issuance date of August 18, 2026. Key assumptions as of March 31, 2026 were as follows:

Input

  ​ ​ ​

Value

Stock price as of valuation date

$

0.20

Equity volatility

89.0

%

Risk-free rate

3.7

%

Expected term

0.46 year

Drift term

3.6

%

Derivative Liabilities

The change in fair value of derivative liabilities resulted in a loss of approximately $58,000 and $34,000 for the three months ended March 31, 2026 and 2025, respectively, which were recorded as a component of other income on the accompanying consolidated statements of operations and comprehensive loss.

Shares to be issued at settlement of derivative liabilities

The shares of the Company’s common stock to be issued in settlement of the above derivative liabilities are dependent on the share price at a future date and, as such, cannot be exactly determined as of March 31, 2026. Accordingly, an estimate has been made using the option pricing model to determine the liability value.